GOLD 2011 versus GOLD 2017 – What does change?

A. Caldas Marçôa (Matosinhos, Portugal)

Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Session: Classifying COPD with multidimensional scores and biomarkers
Session type: Thematic Poster
Number: 1097
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Caldas Marçôa (Matosinhos, Portugal). GOLD 2011 versus GOLD 2017 – What does change?. 1097

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The same COPD patients, different GOLD criteria – what are the consequences of changing GOLD 2007-2011-2017 recommendations?
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018


Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015

Changes in GOLD Classifications: 2011 versus 2017. Do exacerbations have any role in mortality?
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017



GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




New GOLD 2011 guidelines: Is there an improvement?
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012


The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of patients.
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017


Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?
Source: Eur Respir J 2014; 43: 1201-1203
Year: 2014


COPD severity using GOLD 2017 in real life: The French Palomb Cohort
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017


Mortality and exacerbation prediction by GOLD groups ABCD 2011 vs. 2017: analysis of the COPDGene cohort
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017



Differences in the recommended initial therapy of COPD according to GOLD guidelines 2006 and 2011
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012




The distribution of COPD in UK general practice using the 2017 GOLD classification
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017


COPD GOLD stage 1: Is it really a disease?
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011


2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


The 2006 and 2011 GOLD classifications and five-years mortality in COPD
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013

Usefulness of COPD assessment test (CATÔ) for the management of COPD according to GOLD 2011
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012


Efficacy of revefenacin based on GOLD 2017 categories: reanalysis of phase 3 data in patients with COPD
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Implementation of the GOLD 2017 disease classification in a real-life COPD cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




An old disease from a new perspective – GOLD 2011 recommendations for COPD
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012

Late Breaking Abstract - Adherence to GOLD recommendations in Italian COPD patients stratified by GOLD groups A–D: The MISTRAL study
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017


Validation of the GOLD 2017 classification in a Chinese COPD cohort
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017